Holst JJ (2004). „Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors”. Expert Opin Emerg Drugs. 9 (1): 155—66. PMID15155141. doi:10.1517/eoed.9.1.155.32952.
During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN (2003). „Glucagon-like peptide-1 receptor is involved in learning and neuroprotection”. Nat. Med. 9 (9): 1173—9. PMID12925848. doi:10.1038/nm919.
Holst JJ (2004). „Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors”. Expert Opin Emerg Drugs. 9 (1): 155—66. PMID15155141. doi:10.1517/eoed.9.1.155.32952.
During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN (2003). „Glucagon-like peptide-1 receptor is involved in learning and neuroprotection”. Nat. Med. 9 (9): 1173—9. PMID12925848. doi:10.1038/nm919.